Doximity (DOCS) Cash & Equivalents (2021 - 2026)

Doximity (DOCS) has 6 years of Cash & Equivalents data on file, last reported at $219.2 million in Q1 2026.

• On a quarterly basis, Cash & Equivalents rose 4.56% year-over-year to $219.2 million in Q1 2026; TTM through Mar 2026 was $219.2 million, a 4.56% increase from a year earlier, with the FY2026 full-year figure at $219.2 million, up 4.56% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $219.2 million, up from $64.8 million in the prior quarter.
• Over the last five years, Cash & Equivalents for DOCS reached as high as $306.7 million in Q2 2023 and fell as low as $64.8 million in Q4 2025.
• Historically, Cash & Equivalents has averaged $146.3 million across 5 years, with a median of $136.5 million in 2022.
• Across the five-year window, Cash & Equivalents sank 81.48% in 2022 and surged 178.61% in 2023, its largest moves.
• Year by year, Cash & Equivalents stood at $136.5 million in 2022, then fell by 9.79% to $123.1 million in 2023, then jumped by 34.27% to $165.3 million in 2024, then sank by 60.77% to $64.8 million in 2025, then surged by 238.04% to $219.2 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $219.2 million in Q1 2026, $64.8 million in Q4 2025, and $169.2 million in Q3 2025.